What it sells
Catheter-based solution to treat chronic heart failure.
Business model breakdown
Trigger: what makes them buy now?
Heart failure patients continue to have symptoms and hospitalizations despite guideline-directed medical therapy
Workflow: what inputs become what output?
Catheter procedure to interrupt pathological neural signaling in CHF patients with limited options; still in development
Distribution: how it reaches customers
UnverifiedNot applicable yet: pre-commercial device developer; site is a single landing page with contact form
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2022 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.